These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38823460)

  • 1. Mutations, substitutions, and selection: Linking mutagenic processes to cancer using evolutionary theory.
    Cannataro VL; Glasmacher KA; Hampson CE
    Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167268. PubMed ID: 38823460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attribution of Cancer Origins to Endogenous, Exogenous, and Preventable Mutational Processes.
    Cannataro VL; Mandell JD; Townsend JP
    Mol Biol Evol; 2022 May; 39(5):. PubMed ID: 35580068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic base substitution patterns in diverse species reveal links to cancer and metabolism.
    Gelova SP; Doherty KN; Alasmar S; Chan K
    Genetics; 2022 Nov; 222(3):. PubMed ID: 36149294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer.
    Kim YA; Wojtowicz D; Sarto Basso R; Sason I; Robinson W; Hochbaum DS; Leiserson MDM; Sharan R; Vadin F; Przytycka TM
    Genome Med; 2020 May; 12(1):52. PubMed ID: 32471470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-cancer analysis of whole genomes.
    ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium
    Nature; 2020 Feb; 578(7793):82-93. PubMed ID: 32025007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
    Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
    PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finding cancer driver mutations in the era of big data research.
    Poulos RC; Wong JWH
    Biophys Rev; 2019 Feb; 11(1):21-29. PubMed ID: 29611034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The shaping of cancer genomes with the regional impact of mutation processes.
    Lee SY; Wang H; Cho HJ; Xi R; Kim TM
    Exp Mol Med; 2022 Jul; 54(7):1049-1060. PubMed ID: 35902761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma.
    Cannataro VL; Gaffney SG; Sasaki T; Issaeva N; Grewal NKS; Grandis JR; Yarbrough WG; Burtness B; Anderson KS; Townsend JP
    Oncogene; 2019 May; 38(18):3475-3487. PubMed ID: 30647454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational signatures and processes in hepatobiliary cancers.
    Zhuravleva E; O'Rourke CJ; Andersen JB
    Nat Rev Gastroenterol Hepatol; 2022 Jun; 19(6):367-382. PubMed ID: 35273358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring background mutational processes to decipher cancer genetic heterogeneity.
    Goncearenco A; Rager SL; Li M; Sang QX; Rogozin IB; Panchenko AR
    Nucleic Acids Res; 2017 Jul; 45(W1):W514-W522. PubMed ID: 28472504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep learning model accurately classifies metastatic tumors from primary tumors based on mutational signatures.
    Zheng W; Pu M; Li X; Du Z; Jin S; Li X; Zhou J; Zhang Y
    Sci Rep; 2023 May; 13(1):8752. PubMed ID: 37253775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of mutational and copy number signatures in human cancer.
    Steele CD; Pillay N; Alexandrov LB
    J Pathol; 2022 Jul; 257(4):454-465. PubMed ID: 35420163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.
    Meier B; Volkova NV; Gerstung M; Gartner A
    DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers.
    Guo J; Zhou Y; Xu C; Chen Q; Sztupinszki Z; Börcsök J; Xu C; Ye F; Tang W; Kang J; Yang L; Zhong J; Zhong T; Hu T; Yu R; Szallasi Z; Deng X; Li Q
    Cancer Res; 2021 Aug; 81(16):4205-4217. PubMed ID: 34215622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the Drivers of Tumorigenesis in the Context of Evolution: Theoretical Models and Bioinformatics Tools.
    Zhu X; Zhao W; Zhou Z; Gu X
    J Mol Evol; 2023 Aug; 91(4):405-423. PubMed ID: 37246992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding mutagenesis through delineation of mutational signatures in human cancer.
    Petljak M; Alexandrov LB
    Carcinogenesis; 2016 Jun; 37(6):531-40. PubMed ID: 27207657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA.
    Bergstrom EN; Luebeck J; Petljak M; Khandekar A; Barnes M; Zhang T; Steele CD; Pillay N; Landi MT; Bafna V; Mischel PS; Harris RS; Alexandrov LB
    Nature; 2022 Feb; 602(7897):510-517. PubMed ID: 35140399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensively Exploring the Mutational Landscape and Patterns of Genomic Evolution in Hypermutated Cancers.
    Lin PC; Yeh YM; Hsu HP; Chan RH; Lin BW; Chen PC; Pan CC; Hsu KF; Hsiao JR; Shan YS; Shen MR
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic Molecular Processes: Impact on Mutagenesis.
    Lim B; Mun J; Kim SY
    Trends Cancer; 2017 May; 3(5):357-371. PubMed ID: 28718413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.